Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Takeda-6d is a novel, potent DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with IC50 of 7.0 nM and 2.2 nM, respectively.
説明 | Takeda-6d is a novel, potent DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with IC50 of 7.0 nM and 2.2 nM, respectively. |
ターゲット&IC50 | Raf:7.0 nM, VEGFR2:2.2 nM |
分子量 | 547.99 |
分子式 | C27H19ClFN5O3S |
CAS No. | 1125632-93-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 65 mg/ml (118.62 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Takeda-6d 1125632-93-0 Angiogenesis Tyrosine Kinase/Adaptors VEGFR antitumor HUVEC cells inhibit antiangiogenesis Raf Vascular endothelial growth factor receptor PKR-like endoplasmic reticulum kinase orally active Takeda-6D Inhibitor Takeda 6d PERK Takeda6d Raf kinases Protein kinase R-like endoplasmic reticulum kinase inhibitor